Cooley advises Vaxcyte on the offering, and Latham & Watkins advises the underwriters. Vaxcyte, Inc. (Nasdaq: PCVX) has announced the pricing of an underwritten public offering...
Vaxcyte’s $500 Million Public Offering
Mirion Technologies’ $85.6 Million Secondary Offering
Goodwin Procter advised Mirion Technologies on the offering, and Davis Polk advised the underwriter. Mirion Technologies announced the $85.6 million offering of 9,786,153 shares of its Class...
Travere Therapeutics’ $200 Million Public Offering of Common Stock and Pre-Funded Warrants
Cooley advises Travere Therapeutics, and Latham & Watkins advises the underwriters. Travere Therapeutics, Inc. (Nasdaq: TVTX) has announced the pricing of an underwritten public offering of...
InterDigital’s $200 Million Modified Dutch Auction Tender Offer
Paul Weiss represented InterDigital, and Simpson Thacher represented the dealer manager in the operation. InterDigital, Inc. announced a modified “Dutch auction” tender offer for up to...
ImmunityBio’s $50.0 Million Offering
Goodwin Procter advised Jefferies LLC as exclusive placement agent on the deal. ImmunityBio, Inc. (NASDAQ: IBRX), a clinical-stage immunotherapy company, announced that it has executed financing...
Israel Discount Bank’s Senior Bonds Offering
Herzog advised the underwriters on the deal. Israel Discount Bank executed a $800 million senior bonds offering. This is the first international bonds offering for Israel Discount...
Xponential Fitness’ $122.5 Million Secondary Offering of Class A Common Stock
Davis Polk is advising Xponential Fitness on the offering, and Latham & Watkins is advising the underwriters involved. Xponential Fitness, Inc. has announced the pricing of...
CureVac’s $250 Million Common Shares Offering
NautaDutilh and Davis Polk advised CureVac on the offering, while Latham & Watkins advised the underwriters involved. CureVac N.V. announced the pricing of 27,027,028 common shares...
Structure Therapeutics’ $185.3 Million IPO
Cooley LLP represented Structure Therapeutics, while Latham & Watkins LLP represented the underwriters in the offering. Structure Therapeutics, a clinical-stage global biopharmaceutical company, announced its $185.3 million...
Cellectis’ $25 Million Increase in Capital
Gide advised the banking syndicate composed of Jefferies LLC and Barclays Capital Inc. in connection with the capital increase of Cellectis. The banks were represented by...
Formycon AG’s €70 Million Capital Increase
Taylor Wessing advised Formycon AG on the deal. Norton Rose Fulbright advised the banks. Formycon AG closed a capital increase by executing an accelerated bookbuilding. In this...
Garda World Security’s $400 Million Notes Offering
McCarthy Tétrault acted as Canadian counsel to the initial purchasers. On January, 30, 2023, Garda World Security Corporation (TSX: GW) closed the private offering of US$400 million aggregate...